NASDAQ:AEMD

Aethlon Medical - AEMD Stock Forecast, Price & News

$1.34

-0.02 (-1.47%)

(As of 08/15/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.26
▼
$1.37
50-Day Range: $0.94
▼
$1.99
52-Week Range: $0.88
▼
$5.99

Volume: 1.88 million shs
Average Volume: 1.86 million shs
Market Capitalization: $22.29 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.00

Aethlon Medical MarketRank™ Forecast

Analyst Rating: N/A
0.00 Rating Score
Upside/Downside: 198.5% Upside
$4.00 Price Target
Short Interest: Healthy
0.78% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.26
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Medical Sector

1009th out of 1,125 stocks

Surgical & Medical Instruments Industry

96th out of 113 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $4.00, Aethlon Medical has a forecasted upside of 198.5% from its current price of $1.34.
Amount of Analyst Coverage
Aethlon Medical has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.78% of the outstanding shares of Aethlon Medical have been sold short.
Short Interest Ratio / Days to Cover
Aethlon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Aethlon Medical has recently decreased by 78.69%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Aethlon Medical does not currently pay a dividend.
Dividend Growth
Aethlon Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AEMD.

4.0

News and Social Media Coverage

News Sentiment
Aethlon Medical has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Aethlon Medical this week, compared to 0 articles on an average week.
Social Mentions This Week
MarketBeat has tracked 3 reddit mentions for Aethlon Medical this week, compared to 0 mentions on an average week.
Search Interest
39 people have searched for AEMD on MarketBeat in the last 30 days. This is an increase of 875% compared to the previous 30 days.
MarketBeat Follows
12 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aethlon Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.20% of the stock of Aethlon Medical is held by insiders.
Percentage Held by Institutions
Only 10.58% of the stock of Aethlon Medical is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Aethlon Medical is -1.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aethlon Medical is -1.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Aethlon Medical has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Aethlon Medical (NASDAQ:AEMD) Stock

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Aethlon Medical Price Performance

NASDAQ:AEMD opened at $1.36 on Monday. The business's 50-day moving average price is $1.15 and its 200 day moving average price is $1.25. Aethlon Medical has a 52-week low of $0.88 and a 52-week high of $5.99.

Aethlon Medical (NASDAQ:AEMD - Get Rating) last announced its earnings results on Tuesday, June 28th. The medical equipment provider reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.13). Aethlon Medical had a negative net margin of 3,542.86% and a negative return on equity of 59.57%. The company had revenue of $0.01 million during the quarter, compared to analysts' expectations of $1.02 million. On average, equities analysts forecast that Aethlon Medical will post 0.78 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Aethlon Medical to a "sell" rating in a research report on Friday.

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Stock News Headlines

August 15, 2022 | finance.yahoo.com

Aethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The Corner

August 15, 2022 | americanbankingnews.com

Aethlon Medical (NASDAQ:AEMD) Rating Increased to Sell at StockNews.com

August 10, 2022 | seekingalpha.com

Aethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q1 2023 Results - Earnings Call Transcript

August 10, 2022 | finance.yahoo.com

Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox

August 7, 2022 | americanbankingnews.com

Aethlon Medical (AEMD) to Release Quarterly Earnings on Tuesday

August 3, 2022 | finance.yahoo.com

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

August 3, 2022 | americanbankingnews.com

Stock Traders Purchase Large Volume of Aethlon Medical Call Options (NASDAQ:AEMD)

July 29, 2022 | americanbankingnews.com

Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Expands By 223.0%

July 28, 2022 | finance.yahoo.com

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

July 11, 2022 | nasdaq.com

FDA Approves Aethlon Medical's Protocol Amendment For COVID-19 Trial

June 29, 2022 | seekingalpha.com

Aethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q4 2022 Results - Earnings Call Transcript

June 29, 2022 | finance.yahoo.com

AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkeypox

June 28, 2022 | seekingalpha.com

Aethlon Medical Q4 2022 Earnings Preview

June 27, 2022 | benzinga.com

Earnings Outlook For Aethlon Medical

June 21, 2022 | finance.yahoo.com

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

May 24, 2022 | finance.yahoo.com

/C O R R E C T I O N -- Aethlon Medical, Inc./

May 21, 2022 | finance.yahoo.com

Is Aethlon Medical (NASDAQ:AEMD) In A Good Position To Deliver On Growth Plans?

May 9, 2022 | finance.yahoo.com

AEMD: Effectiveness of Hemopurifier on COVID-19 Variants In Vitro Indicates Device’s Potential Range

May 2, 2022 | finance.yahoo.com

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

February 15, 2022 | finance.yahoo.com

AEMD: Positive Takeaways from Plan to Expand Clinical Efforts

February 13, 2022 | benzinga.com

Aethlon Medical's Earnings Outlook

February 11, 2022 | seekingalpha.com

Aethlon Medical Q3 2022 Earnings Preview

January 31, 2022 | finance.yahoo.com

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

November 30, 2021 | finance.yahoo.com

Here's Why We're Not Too Worried About Aethlon Medical's (NASDAQ:AEMD) Cash Burn Situation

November 12, 2021 | finance.yahoo.com

AEMD: Strong balance sheet, expanded management team & new CRO relationship expected to facilitate clinical efforts

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Company Calendar

Last Earnings: 6/28/2022
Today: 8/15/2022
Next Earnings (Estimated): 11/08/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AEMD
CUSIP: N/A
CIK: 773910
Web: www.aethlonmedical.com
Phone: (858) 459-7800
Fax: N/A
Employees: 10
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $4.00
High Stock Price Forecast: $4.00
Low Stock Price Forecast: $4.00
Forecasted Upside/Downside: +198.5%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.73)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 1.72
P/E Growth: N/A
Net Income: $-10,420,000.00
Net Margins: -3,542.86%
Pretax Margin: -6,931.48%
Return on Equity: -59.57%
Return on Assets: -54.53%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.66
Quick Ratio: 9.66

Sales & Book Value

Annual Sales: $290,000.00
Price / Sales: 76.88
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.10 per share
Price / Book: 1.22

Miscellaneous

Outstanding Shares: 16,638,000
Free Float: 16,106,000
Market Cap: $22.29 million
Optionable: Not Optionable
Beta: 0.77

Key Executives

Dr. Charles J. Fisher Jr. (Age 75)
M.D., CEO, Director & Member of Extracorporeal Therapy Advisory Board
Comp: $509.14k
Mr. James B. Frakes M.B.A. (Age 65)
CFO, Sr. VP of Fin. & Sec.
Comp: $385k
Mr. Steven P. Larosa M.D.
Chief Medical Officer & Acting Chief Scientific Officer
Mr. Guy F. Cipriani BS (Eng.) (Age 52)
MBA, Sr. VP, Chief Bus. Officer & Director
Comp: $29.75k
Mr. Sunil Sawhney
Head of Clinical Studies
Dr. Richard H. Tullis Ph.D. (Age 77)
Consultant

Key Competitors

View All Competitors

Insiders & Institutions

Natixis
Bought 25,000 shares on 8/12/2022
Ownership: 0.150%

View All Insider Transactions
View All Institutional Transactions

AEMD Stock - Frequently Asked Questions

What is Aethlon Medical's stock price forecast for 2022?: 0 brokers have issued 12-month price targets for Aethlon Medical's stock. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 198.5% from the stock's current price.
View analysts price targets for AEMD or view top-rated stocks among Wall Street analysts.
How have AEMD shares performed in 2022?: Aethlon Medical's stock was trading at $1.86 on January 1st, 2022. Since then, AEMD stock has decreased by 28.0% and is now trading at $1.34.
View the best growth stocks for 2022 here.
When is Aethlon Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our AEMD earnings forecast.
How were Aethlon Medical's earnings last quarter?: Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Tuesday, June, 28th. The medical equipment provider reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.13. The medical equipment provider had revenue of $0.01 million for the quarter, compared to analyst estimates of $1.02 million. Aethlon Medical had a negative trailing twelve-month return on equity of 59.57% and a negative net margin of 3,542.86%.

What other stocks do shareholders of Aethlon Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).
What is Aethlon Medical's stock symbol?: Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."
Who are Aethlon Medical's major shareholders?: Aethlon Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Natixis (0.15%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.
How do I buy shares of Aethlon Medical?: Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Aethlon Medical's stock price today?: One share of AEMD stock can currently be purchased for approximately $1.34.
How much money does Aethlon Medical make?: Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $22.29 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis.
How can I contact Aethlon Medical?: Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.

This page (NASDAQ:AEMD) was last updated on 8/15/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Aethlon Medical - AEMD Stock Forecast, Price & News

Aethlon Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Social Mentions This Week

Search Interest

MarketBeat Follows